Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Covington
Cipla
Express Scripts
Dow
Merck
QuintilesIMS
Colorcon
Medtronic

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084930

« Back to Dashboard

NDA 084930 describes ERGOLOID MESYLATES, which is a drug marketed by Mutual Pharm, Sun Pharm Industries, Watson Labs, Kv Pharm, Lederle, Superpharm, and Vangard, and is included in twenty NDAs. It is available from two suppliers. Additional details are available on the ERGOLOID MESYLATES profile page.

The generic ingredient in ERGOLOID MESYLATES is ergoloid mesylates. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ergoloid mesylates profile page.
Summary for 084930
Tradename:ERGOLOID MESYLATES
Applicant:Watson Labs
Ingredient:ergoloid mesylates
Patents:0
Therapeutic Class:Antidementia Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 084930

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;SUBLINGUALStrength0.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Citi
Fuji
Julphar
Harvard Business School
Boehringer Ingelheim
US Department of Justice
Chinese Patent Office
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.